4.7 Article

Human embryonic stem cell-derived dopaminergic neurons reverse functional deficit in Parkinsonian rats

Journal

STEM CELLS
Volume 26, Issue 1, Pages 55-63

Publisher

WILEY-BLACKWELL
DOI: 10.1634/stemcells.2007-0494

Keywords

dopaminergic neurons; cell therapy; transplantation; Parkinson disease; rats

Funding

  1. EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER
  2. NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS046587, R01NS045926] Funding Source: NIH RePORTER
  3. NICHD NIH HHS [P30-HD03352, P30 HD003352-41, P30 HD003352] Funding Source: Medline
  4. NINDS NIH HHS [R01 NS045926-04, U01-NS046587, U01 NS046587-03, U01 NS046587, R01-NS045926, R01 NS045926] Funding Source: Medline

Ask authors/readers for more resources

We show that human embryonic stem cell-derived dopaminergic neurons survived transplantation to the neurotoxin 6-hydroxydopamine-lesioned rat striatum and, in combination with the cells newly differentiated from their progenitors, contributed to locomotive function recovery at 5 months. The animal behavioral improvement was correlated with the dopamine neurons present in the graft. Although the donor cells contained forebrain and midbrain dopamine neurons, the dopamine neurons present in the graft mainly exhibited a midbrain, or nigra, phenotype, suggesting the importance of midbrain dopamine neurons in functional repair. Furthermore, progenies of grafted cells were neurons and glia with greatly diminished mitotic activity by 5 months. Thus, the in vitro-produced human dopamine neurons can functionally engraft in the brain.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available